sglt2 and glp 1 combination Effect of treatment with glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Cardiovascular benefits of SGLT2 inhibitors

Piazza, MD, FACS | Board-Certified Plastic Surgeon In the ever-evolving landscape of health and wellness, there's a buzz around a peptide that has caught the attention of influential figures like Andrew Huberman and Joe Rogan

Beta-alanine delays fatigue, limiting the burning sensation you feel when pushing your muscles to failure, and allowing you to train for longer

Always source from a reputable, U.S.-based supplier that provides recent, third-party lab testing results (like HPLC and Mass Spectrometry) for every batch

The evidence is weak

If orforglipron receives approval for obesity in April 2026, it will enter a market that Morgan Stanley estimates could reach $100 billion annually by the early 2030s, potentially transforming Eli Lilly's already dominant position in the metabolic disease space